The Cochrane Fertility Regulation Group: synthesizing the best evidence about family planning

Contraception

Volumn 74, Issue 4, 2006, Pages 280-286

  Helmerhorst, Frans M ^a   Belfield, Toni ^a,b   Kulier, Regina ^a,c   Maitra, Nandita ^d   O'Brien, Paul ^a,e   Grimes, David A ^a,f  

^a Fertility Regulation Group of the Cochrane Collaboration   (Netherlands)

^b Family Planning Association   (United Kingdom)

^c WHO Collaborating Centre in Education and Research in Human Reproduction   (Switzerland)

^d Baroda Medical College   (India)

^e Raymede Clinic   (United Kingdom)

^f Biomedical Affairs   (United States)

Author keywords

Cochrane; Contraception; Fertility regulation; Randomized controlled trial; Systematic review

Indexed keywords

CHINESE DRUG; COPPER INTRAUTERINE DEVICE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT;

ABORTION; AMENORRHEA; ARTICLE; BARRIER CONTRACEPTION; BODY WEIGHT; BREAST FEEDING; CHINESE MEDICINE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; DECISION MAKING; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EMERGENCY CONTRACEPTION; ENDOSCOPIC SURGERY; EVIDENCE BASED MEDICINE; FAMILY PLANNING; FEMALE INFERTILITY; FEMALE STERILIZATION; FERTILITY; FOOD AND DRUG ADMINISTRATION; GOOD CLINICAL PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HERBAL MEDICINE; HORMONAL CONTRACEPTION; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; LACTATION; LACTATIONAL AMENORRHEA; LAPAROTOMY; MALE STERILIZATION; ORAL CONTRACEPTION; OVARY CYST; PAIN; PATIENT EDUCATION; PREGNANCY; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; REPRODUCTION; RESOURCE ALLOCATION; SYSTEMATIC REVIEW; UTERINE TUBE LIGATION; VAGINA BLEEDING; VASECTOMY;

CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; COUNSELING; DRUG INDUSTRY; FAMILY PLANNING SERVICES; FEMALE; FERTILITY; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SEX EDUCATION;

EID: 33748750244     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.04.004     Document Type: Article

References (64)

1. AbouZahr C. Safe motherhood: a brief history of the global movement 1947-2002. Br Med Bull 67 (2003) 13-25
2. Penney G. A new clinical effectiveness unit for the faculty of family planning and reproductive health care. J Fam Plann Reprod Health Care 28 (2002) 176-177
3. Grimes D.A. Evidence-based family planning: the paradigm for the third millennium. Eur J Contracept Reprod Health Care 5 (2000) 287-294
4. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. 4.2.5. [updated May 2005].www.cochrane.dk/cochrane/handbook/hbook.htm (accessed April 19, 2006).
5. Kuyoh M.A., Toroitich-Ruto C., Grimes D.A., Schulz K.F., and Gallo M.G. Sponge versus diaphragm for contraception. Cochrane Database Syst Rev (2002) CD003172
6. Gallo M.F., Nanda K., Grimes D.A., and Schulz K.F. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (2005) CD003989
7. Gallo M.F., Grimes D.A., Schulz K.F., and Helmerhorst F.M. Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol 103 (2004) 359-373
8. Cook D.J., Mulrow C.D., and Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126 (1997) 376-380
9. Nardin J.M., Kulier R., and Boulvain M. Techniques for the interruption of tubal patency for female sterilisation. Cochrane Database Syst Rev (2003) CD003034
10. Halpern V., Gallo M.F., Grimes D.A., and Lopez L. Strategies to improve compliance and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev (2006)
11. Grimes D.A., and Schulz K.F. Antibiotic prophylaxis for intrauterine contraceptive device insertion. (Cochrane Review). Cochrane Database Syst Rev 2 (2001) CD001327
12. Gallo MF, Grimes DA, Schulz KF. Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 2003;CD03550.
13. Cheng L., Gulmezoglu A.M., Oel C.J., Piaggio G., Ezcurra E., and Van Look P.F. Interventions for emergency contraception. Cochrane Database Syst Rev (2004) CD001324
14. Gallo M.F., Grimes D.A., and Schulz K.F. Cervical cap versus diaphragm for contraception. Cochrane Database Syst Rev (2003) CD003551
15. Kulier R., Gulmezoglu A.M., Hofmeyr G.J., Cheng L.N., and Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev (2004) CD002855
16. Schulz K.F., Chalmers I., Hayes R.J., and Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
17. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 (1996) 637-639
18. de Craen A.J., van Vliet H.A., and Helmerhorst F.M. An analysis of systematic reviews indicated low incorporation of results from clinical trial quality assessment. J Clin Epidemiol 58 (2005) 311-313
19. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
20. Altman D.G. The scandal of poor medical research. BMJ 308 (1994) 283-284
21. Grimes D.A., and Schulz K.F. Randomized controlled trials in "Contraception": the need for "CONSORT" guidelines. Contraception 64 (2001) 139-142
22. Moher D., Jones A., and Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 285 (2001) 1992-1995
23. Mills E., Loke Y.K., Wu P., Montori V.M., Perri D., Moher D., et al. Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol 58 (2004) 61-65
24. Moher D., Soeken K., Sampson M., Ben-Porat L., and Berman B. Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine. BMC Pediatr 2 (2002) 2
25. Schulz K.F., and Grimes D.A. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 359 (2002) 781-785
26. Altman D.G., Schulz K.F., Moher D., Egger M., Davidoff F., Elbourne D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
27. Sulak P., Lippman J., Siu C., Massaro J., and Godwin A. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. Contraception 59 (1999) 161-166
28. Phillips A., and Haudiquet V. ICH E9 guideline 'Statistical principles for clinical trials': a case study. Stat Med 22 (2003) 1-11 [discussion, 13-7]
29. Trussell J. Methodological pitfalls in the analysis of contraceptive failure. Stat Med 10 (1991) 201-220
30. Burkman R.T. Clinical pearls: factors affecting reported contraceptive efficacy rates in clinical studies. Int J Fertil Women's Med 47 (2002) 153-161
31. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev 9 (1997) 15-21
32. Chalmers I. Underreporting research is scientific misconduct. JAMA 263 (1990) 1405-1408
33. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., and Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 295 (2006) 676-680
34. DeAngelis C.D., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 292 (2004) 1363-1364
35. Hubacher D., Lara-Ricalde R., Taylor D.J., Guerra-Infante F., and Guzman-Rodriguez R. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 345 (2001) 561-567
36. Haynes R.B., Sackett D.L., Guyatt G.H., and Tugwell P. Clinical epidemiology. How to do clinical practice research. 3rd ed. (2006), Lippincott Williams and Wilkins, Philadelphia
37. Grimes D.A., and Schulz K.F. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 105 (2005) 1114-1118
38. US Food and Drug Administration. Black box warning added concerning long-term use of Depo-Provera contraceptive injection. FDA Talk Paper T04-50, November 17, 2004.
39. World Health Organization. WHO statement on hormonal contraception and bone health. http://www.who.int/reproductive-health/family_planning/bone_health.html [accessed March 27, 2006]
40. Trussell J., and Kost K. Contraceptive failure in the United States: a critical review of the literature. Stud Fam Plann 18 (1987) 237-283
41. Trussell J. Analyzing contraceptive failure. J Reprod Med 44 (1999) 478-479 [discussion, 480-1]
42. Farley T.M. Life-table methods for contraceptive research. Stat Med 5 (1986) 475-489
43. Maitra N., Kulier R., Bloemenkamp K.W., Helmerhorst F.M., and Gulmezoglu A.M. Progestogens in combined oral contraceptives for contraception. Cochrane Database Syst Rev (2004) CD004861
44. Belsey E.M., and Farley T.M. The analysis of menstrual bleeding patterns: a review. Contraception 38 (1988) 129-156
45. Audet M.C., Moreau M., Koltun W.D., Waldbaum A.S., Shangold G., Fisher A.C., et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: a randomized controlled trial. JAMA 285 (2001) 2347-2354
46. Fu H., Darroch J.E., Haas T., and Ranjit N. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam Plann Perspect 31 (1999) 56-63
47. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol 100 (1993) 516-523
48. Glasier A., and Baird D. The effects of self-administering emergency contraception. N Engl J Med 339 (1998) 1-4
49. Raine T.R., Harper C.C., Rocca C.H., Fischer R., Padian N., Klausner J.D., et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 293 (2005) 54-62
50. Lexchin J., Bero L.A., Djulbegovic B., and Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326 (2003) 1167-1170
51. Als-Nielsen B., Chen W., Gluud C., and Kjaergard L.L. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA 290 (2003) 921-928
52. Kemmeren J.M., Algra A., and Grobbee D.E. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ 323 (2001) 131-134
53. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline. Guideline for Good Clinical Practice E6. http://www.ich.org/MediaServer.jser?@_ID=482&@_MODE=GLB [accessed April 12, 2004]
54. Grimes D.A., Hubacher D., Nanda K., Schulz K.F., Moher D., and Altman D.G. The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet 366 (2005) 172-174
55. Committee for Proprietary Medicinal Products. Note for guidance on clinical investigation of steroid contraceptives in women. http://www.emea.eu.int/pdfs/human/ewp/051998.pdf [accessed January 23, 2006]
56. Van Vliet H., Grimes D.A., Helmerhorst F., and Schulz K. Biphasic versus monophasic oral contraceptives for contraception. (Cochrane Review). Cochrane Database Syst Rev 2 (2001) CD002032
57. Arowojolu A.O., Gallo M.F., Grimes D.A., and Garner S.E. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev (2004) CD004425
58. Cook L., Nanda K., and Grimes D. Diaphragm versus diaphragm with spermicides for contraception. Cochrane Database Syst Rev (2003) CD002031
59. In: Hannaford P., and Webb A. (Eds). Evidence-guided prescribing of the pill 54 (1996), Parthenon Publishing, Carnforth (England)
60. Hannaford P.C., and Webb A.M. Evidence-guided prescribing of combined oral contraceptives: consensus statement. An international workshop at Mottram Hall, Wilmslow, UK, March. Contraception 54 (1996) 125-129
61. World Health Organization. Selected practice recommendations for contraceptive use. http://www.who.int/reproductive-health/publications/spr/ [accessed January 23, 2006]
62. World Health Organization. Medical eligibility criteria for contraceptive use, third ed. http://www.who.int/reproductive-health/publications/MEC_3/index.htm [accessed February 11, 2005]
63. Funai E.F., Rosenbush E.J., Lee M.J., and Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 51 (2001) 8-11
64. Glasziou P., Vandenbroucke J.P., and Chalmers I. Assessing the quality of research. BMJ 328 (2004) 39-41